亿胜生物科技（01061）于2026年6月2日发布截至2026年5月31日的证券变动月报表。公告显示，公司注册股本维持1,000,000,000股普通股，面值为每股0.1港元，注册股本总额为100,000,000港元，与上月底一致。
报告期内，公司已发行股份（不含库存股份）数量为567,006,000股，库存股份数量为0股，合计总数继续保持在567,006,000股，未出现新增发行、回购、注销或库藏股变动。公司确认已满足最低公众持股量要求。
关于股份期权，公司根据股东大会通过的购股权计划，持有57,064,900份尚未行使的期权，报告期内并未因该计划新增发行股份或转让库存股份。报告期内不存在可换股票据或其他发行协议变动。
截至5月末，公司股本数量保持稳定。公告由董事方海洲签署并强调，公司严格遵守香港联交所《上市规则》以及其他相关法律法规的要求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.